Pharmacological Effects of JTT-551, a Novel Protein Tyrosine Phosphatase 1B Inhibitor, in Diet-Induced Obesity Mice

Pharmacological Effects of JTT-551, a Novel Protein Tyrosine Phosphatase 1B Inhibitor, in Diet-Induced Obesity Mice

Saved in:

Bibliographic Details
Main Authors:	Makoto Ito, Sumiaki Fukuda, Shohei Sakata, Hisayo Morinaga, Takeshi Ohta
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2014/680348
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Improves Hyperglycemia and Dyslipidemia Independent of Suppression of Food Intake in Diabetic Rats
by: Shohei Sakata, et al.
Published: (2014-01-01)

Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease
by: Thomas F Baumert, et al.
Published: (2025-01-01)

Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat
by: Shohei Sakata, et al.
Published: (2014-01-01)

Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors
by: Maria Antonietta Lucci, et al.
Published: (2010-01-01)

Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
by: Athika Rampadarath, et al.
Published: (2022-01-01)

Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo
by: Chien-Wei Feng, et al.
Published: (2020-01-01)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
by: Evan Pisick, et al.
Published: (2004-01-01)

Effects of Src Kinase Inhibition on Expression of Protein Tyrosine Phosphatase 1B after Brain Hypoxia in a Piglet Animal Model
by: Dimitrios Angelis, et al.
Published: (2017-01-01)

Prognostic importance of human leukocyte antigen DRβ1 gene and protein tyrosine phosphatase nonreceptor Type 22 gene polymorphism in rheumatoid arthritis
by: Pramod Kumar Verma, et al.
Published: (2017-01-01)

The protein tyrosine phosphatase, nonreceptor type 22-1858C->T (rs2476601) polymorphism is not a genetic risk factor for systemic lupus erythematosus in Indian Tamils
by: Panneer Devaraju, et al.
Published: (2017-01-01)

Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy
by: Oluwaseye Adedirin, et al.
Published: (2025-02-01)

Selective Sensing of Tyrosine Phosphorylation in Peptides Using Terbium(III) Complexes
by: Jun Sumaoka, et al.
Published: (2016-01-01)

Arginase Inhibitor in the Pharmacological Correction of Endothelial Dysfunction
by: Mihail V. Pokrovskiy, et al.
Published: (2011-01-01)

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
by: Benjamin M. Heyman, et al.
Published: (2025-02-01)

A review on the potential of Bruton’s tyrosine kinase (Btk) inhibitor – Ibrutinib for treatment of Multiple Myeloma (MM)
by: Sze-Ting Bong, et al.
Published: (2019-05-01)

Utility of Bruton’s Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström’s Macroglobulinemia)
by: Maroun Bou Zerdan, et al.
Published: (2022-01-01)

The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver
by: Indra Radek, et al.
Published: (2024-09-01)

The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatases
by: Geordan J. Stukey, et al.
Published: (2025-01-01)

Single-Molecule Analysis of Alkaline Phosphatase
by: Douglas B. Craig
Published: (2024-10-01)

Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study
by: Chenming Liu, et al.
Published: (2025-02-01)

Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy
by: Shuai Wang, et al.
Published: (2025-02-01)

Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks
by: Mingming Tan, et al.
Published: (2025-01-01)

Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
by: Li Zhang, et al.
Published: (2023-01-01)

Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
by: Soomin Kim, et al.
Published: (2025-02-01)

Deep learning-based CT radiomics predicts prognosis of unresectable hepatocellular carcinoma treated with TACE-HAIC combined with PD-1 inhibitors and tyrosine kinase inhibitors
by: Linan Yin, et al.
Published: (2025-01-01)

Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves’ orbitopathy
by: Yeonjung Yoon, et al.
Published: (2024-09-01)

Combined Effects of 2-Methoxyestradiol (Hypoxia-Inducible Factor 1α Inhibitor) and Dasatinib (A Second-Generation Tyrosine Kinase Inhibitor) on Chronic Myelocytic Leukemia Cells
by: Yuexian Zhang, et al.
Published: (2022-01-01)

Protein Phosphatase 2A: Role in T Cells and Diseases
by: Suyasha Roy, et al.
Published: (2023-01-01)

Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib
by: Vineeth Sukrithan, et al.
Published: (2023-01-01)

Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders
by: Muhammad Waleed Iqbal, et al.
Published: (2025-01-01)

Light-Induced Tyrosine Radical Formation from Ruthenium-Tyrosine Complex Anchored to SnO2 Semiconductor
by: Raed Ghanem
Published: (2008-01-01)

A review of the types of diets used in Crohn’s disease: the support system for pharmacological treatment
by: Joanna Śnieżna, et al.
Published: (2025-01-01)

Present and Future: Pharmacologic Treatment of Obesity
by: Mariela Glandt, et al.
Published: (2011-01-01)

Expression of protein phosphatase 4 in different tissues under hypoxia
by: Yanyan Ma, et al.
Published: (2023-07-01)

Regulation of Endothelial Adherens Junctions by Tyrosine Phosphorylation
by: Alejandro Pablo Adam
Published: (2015-01-01)

Tyrosine hydroxylase of the brain and it’s regulation by glucocorticoids
by: E. V. Sukhareva, et al.
Published: (2016-05-01)

Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid Leukemia
by: Melea A. Ward, et al.
Published: (2015-04-01)

Biochemical characterization of the human ubiquitous glucose‐6‐phosphatase in neutrophil granulocytes
by: Zsigmond Lédeczi, et al.
Published: (2025-02-01)

Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs
by: Gennady G. Yegutkin, et al.
Published: (2014-01-01)

Myotubularin-Related Phosphatase 3 Promotes Growth of Colorectal Cancer Cells
by: Bo’an Zheng, et al.
Published: (2014-01-01)